If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
11.50    -0.50 (-4.17%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £14.39m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Acquisition

30 Apr 2007 07:03

Fabian Romania Property Fund Ltd30 April 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or the "Fund") Fabian Romania announces the purchase of a €60 million office building inBucharest Fabian Romania has reached agreement to purchase its fourth office project, theCubic office development (the "Cubic Centre"), in Bucharest. The Cubic Centrewill be a class A office building with a gross area of approximately 44,000square metres, located in North Bucharest. The building is being developed bythe Kendama, an experienced local developer in Romania. Construction hascommenced and completion is anticipated in the second quarter of 2009. The Cubic Centre will upon completion of construction provide a net lettableoffice area of 27,000 square metres over 12 floors, together with 533 carspaces. The building is located in a prominent location in the Pipera districtof North Bucharest and is likely to attract international tenants seeking classA office space. Vacancy rates for class A office space in in Bucharest are lessthan 3%. The acquisition is due to complete, subject to certain conditions, in twostages. The Fund will pay a first instalment of €12.25 million, of which €5million has already been paid in the form of a secured loan. At practicalcompletion of the building by the developer, the Fund will pay the finalinstalment based upon a forward purchase yield of 7.4% - 7.8% applied to rentsachieved. Based upon current rental estimates, the total value of thetransaction is estimated to be approximately of €60 million. The total equityrequirement for the fund is estimated to be €12 million. Commenting on the transaction, Mark Holdsworth, Managing Director of FabianCapital, the Investment Advisor to the Fund said: "We are delighted that the Fund has sealed its first investment since Admissionto AIM on favourable terms in what is a highly competitive market. The CubicCentre will provide a high quality addition to the Fund's portfolio of officebuildings. It will also give diversification geographically within the city bothin terms of building type and expected tenant mix." Mark Owen, Director responsible for acquisitions comments: "The new office development is in a prominent location in the rapidly expandingoffice location of the northern Pipera district of the City. This area will befurther enhanced by the new motorway link into the City. The Cubic Centre,which is already under construction on a fixed price basis, is well positionedto capitalise on the demand for Class A office space expected. We are already inearly discussions with a number of quality tenants seeking to upgrade theiroffice accommodation." The lead advisers on the transaction were Eurisko (property agent), WSP(technical advisers) and NNDKP (legal adviser). END For Comments:Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLP +44 20 7936 3000James Lewis Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Nov 200810:31 amRNSHolding(s) in Company
31st Oct 20086:27 pmRNSStatement re acquisition of shares
27th Oct 20087:00 amRNSQ3 Net Asset Value
29th Sep 20087:00 amRNSInterim Results
24th Sep 20087:00 amRNSNotice of Interim Results
30th Jul 20087:00 amRNSNet Asset Value(s)
24th Jul 20087:00 amRNSResult of AGM
26th Jun 20084:50 pmRNSAnnual Report and Accounts
24th Jun 20087:00 amRNSFinal Results
17th Jun 20087:00 amRNSNotice of Results
11th Jun 20087:00 amRNSAcquisition
28th Apr 20087:00 amRNSNet Asset Value(s)
13th Mar 200810:48 amRNSHolding(s) in Company
4th Feb 20087:00 amRNSNet Asset Value(s)
21st Jan 20085:50 pmRNSHolding(s) in Company
22nd Nov 20077:02 amRNSDirector/PDMR Shareholding
22nd Nov 20077:01 amRNSChange of Adviser
22nd Oct 20077:01 amRNSNet Asset Value(s)
28th Sep 200710:27 amRNSInterim Results
19th Sep 200710:50 amRNSHolding(s) in Company
16th Aug 20077:00 amRNSRule 26 Notification
3rd Aug 20071:58 pmRNSNet Asset Value(s)
1st Aug 20073:32 pmRNSResult of AGM
11th Jul 20078:16 amRNSUpdate on development
29th Jun 20077:01 amRNSFinal Results
25th Jun 200711:36 amRNSAcquisition
18th Jun 20077:01 amRNSAcquisition
14th Jun 20077:01 amRNSAcquisition
4th Jun 20077:02 amRNSAcquisition
22nd May 20073:28 pmRNSHolding(s) in Company
21st May 20073:23 pmRNSDirector/PDMR Shareholding
17th May 20077:02 amRNSIMG EMEA Conference
30th Apr 20077:03 amRNSAcquisition
23rd Apr 20077:01 amRNSNet Asset Value(s)
9th Feb 20075:59 pmRNSDirector/PDMR Shareholding
29th Jan 20072:36 pmRNSDirector/PDMR Shareholding
22nd Jan 20077:01 amRNSAppointment of Director
22nd Jan 20077:01 amRNSNet Asset Value(s)
19th Dec 20063:48 pmRNSVoting rights and capital
15th Dec 20064:25 pmRNSDirector/PDMR Shareholding
15th Dec 20067:58 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.